Friday, May 20, 2011

US approves new HIV drug

The Food and Drug Administration (FDA) approved a new drug to treat HIV infection on Friday. The drug, made by an arm of Johnson & Johnson, will be sold under the name Edurant, and is designed to be used in combination with other antiretroviral drugs in HIV-positive adults who have not received any prior treatment or therapy.
Side effects included depression, insomnia, headache and rash.

Bloomberg reports that the FDA's approval of the first new anti-HIV drug in three years "clears a hurdle for a planned combination pill with Gilead Science Inc.'s Truvada that may generate more than $1 billion in annual sales."

No comments:

Post a Comment